(Q37829755)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

IGF-1 and atherothrombosis: relevance to pathophysiology and therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Maria Beatrice Musumeci

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Vittoria Mastromarino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Camillo Autore

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Elena Conti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Marco De Giusti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Eleonora Dito

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

377-402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Setting the pace for retinal development: environmental enrichment acts through insulin-like growth factor 1 and brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor I is required for vessel remodeling in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Effects of decreased insulin-like growth factor-1 stimulation on hypoxia inducible factor 1-alpha protein synthesis and function during cutaneous repair in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The somatomedin hypothesis: 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Serum levels of insulin-like growth factor I and its binding proteins in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The insulin-like growth factor-binding protein (IGFBP) superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Regulation of insulin-like growth factor-I (IGF-I) delivery by IGF binding proteins and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Utility of free IGF-I measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor I receptors on blood cells: their relationship to circulating total and "free" IGF-I, IGFBP-1, IGFBP-3 and insulin levels in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Role of insulin-like growth factors in embryonic and postnatal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

IGF2: epigenetic regulation and role in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Interactions of insulin-like growth factor (IGF)-II and growth hormone in vivo: circulating levels of IGF-I and IGF-binding proteins in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Regulation of apoptosis by insulin-like growth factor (IGF)-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Molecular and cellular aspects of the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Regulation of Raf-Akt Cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The insulin-like growth factor system and its pleiotropic functions in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Decreased Reendothelialization and Increased Neointima Formation With Endostatin Overexpression in a Mouse Model of Arterial Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Liposomal IGF-1 gene transfer modulates pro- and anti-inflammatory cytokine mRNA expression in the burn wound

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-1 as a vascular protective factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

IGF-1, oxidative stress and atheroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

IGF-1 receptor inhibitors in clinical trials--early lessons

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Neuroendocrine alterations in obese patients with sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

A substitution model of dietary manipulation is an effective means of optimising lipid profile, reducing C-reactive protein and increasing insulin-like growth factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Lifestyle, anthropometric, and obesity-related physiologic determinants of insulin-like growth factor-1 in the Third National Health and Nutrition Examination Survey (1988-1994).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Microdialysis of insulin-like growth factor-I in human muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Local changes in the insulin-like growth factor system in human skeletal muscle assessed by microdialysis and arterio-venous differences technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Advancing age and insulin resistance: new facts about an ancient history

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Association of testosterone, insulin-like growth factor-I, and C-reactive protein with metabolic syndrome in Chinese middle-aged men with a family history of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Neurotoxicity and "massive" intravenous therapy with penicillin. A study of possible predisposing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor type 1 prevents hyperglycemia-induced uncoupling protein 3 down-regulation and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Circulating endothelial progenitor cells and cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Combining growth factors, stem cells, and gene therapy for the aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Effects of insulin resistance on endothelial progenitor cells and vascular repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Eicosapentaenoic acid protects endothelial cells against anoikis through restoration of cFLIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

GH and IGF-I regulate the expression of endothelial nitric oxide synthase (eNOS) in cardiovascular tissues of hypophysectomized female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-1 receptor activation inhibits oxidized LDL-induced cytochrome C release and apoptosis via the phosphatidylinositol 3 kinase/Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

In stent restenosis: bane of the stent era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: cellular responses to changes in multiple signaling inputs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The chemotactic and mitogenic responses of vascular smooth muscle cells to insulin-like growth factor-I require the activation of ERK1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Metabolic consequences of pregnancy-associated plasma protein-A deficiency in mice: exploring possible relationship to the longevity phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

In vivo analysis of gene expression in long-lived mice lacking the pregnancy-associated plasma protein A (PappA) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

LOX-1 expressed in cultured rat chondrocytes mediates oxidized LDL-induced cell death-possible role of dephosphorylation of Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-I receptors in atherosclerotic plaques of symptomatic and asymptomatic patients with carotid stenosis: effect of IL-12 and IFN-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Increased levels of insulin-like growth factor binding protein-3 in hypertensive patients with carotid atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Polymorphism in the promoter region of the insulin-like growth factor I gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Lack of association between insulin-like growth factor-1 or insulin-like growth factor-binding protein-3 and left ventricular hypertrophy: results of the Study of Health in Pomerania

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Association of insulin-like growth factor-1 receptor gene polymorphisms with left ventricular mass and geometry in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Impaired insulin-like growth factor I vasorelaxant effects in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Vascular insulin-like growth factor-I resistance and diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Aerobic exercise acutely improves insulin- and insulin-like growth factor-1-mediated vasorelaxation in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Release of preformed Ang II from myocytes mediates angiotensinogen and ET-1 gene overexpression in vivo via AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The role of the angiotensin system in cardiac glucose homeostasis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Receptor and nonreceptor tyrosine kinases in vascular biology of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Cardiac-specific overexpression of insulin-like growth factor I (IGF-1) rescues lipopolysaccharide-induced cardiac dysfunction and activation of stress signaling in murine cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-1 prevents Abeta[25-35]/(H2O2)- induced apoptosis in lymphocytes by reciprocal NF-kappaB activation and p53 inhibition via PI3K-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Pretreatment with insulin-like growth factor I protects skeletal muscle cells against oxidative damage via PI3K/Akt and ERK1/2 MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Metformin reverses the deleterious effects of high glucose on osteoblast function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Mechanisms of hypertension in the cardiometabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Leukocytes synthesize angiotensinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Regulation of T-cell function by endogenously produced angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Treatment of experimental myocarditis via modulation of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Effects of ACE-inhibition on IGF-1 and IGFBP-3 concentrations in older adults with high cardiovascular risk profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-1 levels contribute to the development of bacterial translocation in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Widespread targets for friendly fire in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Cardiac functional reserve is diminished in growth hormone-deficient adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Growth hormone and heart failure: oxidative stress and energetic metabolism in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The association of insulin-like-growth factor 1 (IGF-1) with incident coronary heart disease in women: findings from the prospective British Women's Heart and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Serum insulin-like growth factor-I levels and potential risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Differential effects of insulin-like growth factor-1 and atheroma-associated cytokines on cell proliferation and apoptosis in plaque smooth muscle cells of symptomatic and asymptomatic patients with carotid stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Reduced levels of insulin-like growth factor-1 in patients with angina pectoris, positive exercise stress test, and angiographically normal epicardial coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Growth hormone and insulin-like growth factor-1 in acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8- to 9-year-old children in the Avon Longitudinal Study of Parents and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulinlike growth factor-1, insulinlike growth factor binding protein-1, and cognitive function in older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Heart-kidney interactions in ischemic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Longitudinal relation between limited joint mobility, height, insulin-like growth factor 1 levels, and risk of developing microalbuminuria: the Oxford Regional Prospective Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Low insulin-like growth factor-1 and hypocholesterolemia as mortality predictors in acute kidney injury in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Early experience with extended use of insulin-like growth factor-1 in advanced chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

IGF-I system responses during 12 weeks of resistance training in end-stage renal disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Association between IGF-1 and chronic kidney disease among US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Recombinant human insulin-like growth factor-1: a new cardiovascular disease treatment option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Prevention and management of major side effects of targeted agents in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Recombinant human insulin-like growth factor-I decreases serum lipoprotein(a) concentrations in normal adult men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Relationship between insulin-like growth factor-I and low-density lipoprotein cholesterol levels in primary hypothyroidism in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

HDL and triglyceride as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Short- and long-term metabolic effects of recombinant human IGF-I treatment in patients with severe insulin resistance and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Positive association between circulating free insulin-like growth factor–1 levels and coronary flow reserve in arterial systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Effects of Recombinant Human IGF-I/IGF-Binding Protein-3 Complex on Glucose and Glycerol Metabolism in Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100400

21 January 2018

Identifiers

DOI

10.1042/CS20100400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference